Author

Jamie Zheng

Institution: Mayo Clinic

Observed institutions: Mayo Clinic, Bristol-Myers Squibb (United States)

ORCID: 0009-0000-1514-2536

Observed ORCID: 0009-0000-1514-2536

OpenAlex ID: A5032345930

End of induction positron emission tomography complete response (PET‐CR) as a surrogate for progression‐free survival in previously untreated follicular lymphoma

2022 · Jesse G. Dixon, Natalie Dimier, et al. · British Journal of Haematology · 4

Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety Outcomes for Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) and Tisagenlecleucel (tisa-cel) for the Treatment of Third-Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

2024 · Alexander P. Boardman, Juan Luis Reguera, et al. · Blood · 2

A brief harvesting-freezing delay significantly alters the kidney metabolome and leads to false positive and negative results

2024 · Yahya Alsawaf, Igor Maksimovic, et al. · American Journal of Physiology-Renal Physiology · 2

Kidney Volume and Molecular Processes are Dynamic in ADPKD

2026 · Ali Tug, Jamie Zheng, et al. · Kidney International Reports · 1

The Renal Micro-RNA Expression Profile of Pkd1 RC/RC Mice Changes Longitudinally with the Progression of the Disease

2026 · Nalin Sharma, Jamie Zheng, et al. · Kidney360 · 1

Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials

2022 · Jesse G. Dixon, Çağlar Çağlayan, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

Longitudinal Characterization of Mitochondrial and Metabolic Changes in Autosomal Dominant Polycystic Kidney Disease

2022 · Jamie Zheng, Cassandra Trask, et al. · Journal of the American Society of Nephrology

Works count: 7

Citation count: 11

H-index: 2

I10-index: